Through above screening and verification, we found that FAP and CD23, between the No-AIS volunteers and the AIS patients, are intimately related to AIS, suggesting FAP and CD23 are expected to serve as the serum biomarkers. Here, FCER2 is linked to androgen insensitivity syndrome.